Sameen Abedin

Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination

Nicholas R. Waters, P. Hari, M. V. D. van den Brink, 2022, medRxiv.